Barclays updates FTSE stock targets, AstraZeneca and Admiral rise

  • Investing.com
  • Stock Market News
Barclays updates FTSE stock targets, AstraZeneca and Admiral rise
Credit: © Reuters.

LONDON - Barclays (LON: BARC ) has made a series of recalibrations to its price targets on a range of FTSE-listed stocks, reflecting a mix of optimism and caution in its latest assessments. Beazley PLC saw its price target trimmed but retained an 'Overweight' rating at £8.00. Aviva (LON: AV ) PLC enjoyed a modest increase to £4.80, while Admiral Group (LON: ADML ) PLC's target was ambitiously raised to £30.44.

In a contrasting move, Spirax-Sarco Engineering PLC (LON: SPX ) faced a significant cut in its price target to £98.70 but maintained an 'Equal weight' status. AstraZeneca PLC (LON: AZN ) also experienced a reduction in its target, now set at £125.00, yet the pharmaceutical giant continued to hold a 'Buy' rating.

This reshuffling of valuations follows a week of varied adjustments across the financial sector. On Friday, Burberry Group (OTC: BURBY ) PLC's price target was dialed back by Deutsche Bank (ETR: DBKGn ) to £19.50, reflecting a more conservative outlook.

In the FTSE mid-cap sector, Virgin Money (LON: VM ) UK PLC navigated through downgraded forecasts from Citigroup and RBC, with their targets settling between £1.82 and £2.10, respectively. Direct Line Insurance Group PLC and Just Group PLC found favor in Barclays' eyes, as their targets were lifted, enhancing their market positions.

Even smaller-cap entities like Sabre (NASDAQ: SABR ) Insurance Group PLC and Old Mutual (JO: OMUJ ) Limited weren't left out of the adjustments, both receiving slight increases in their Barclays-set valuations.

The recalibrations come amid a broader context of market reevaluations by financial institutions. Peel Hunt and Numis both upgraded Rightmove (OTC: RTMVY ) PLC with a 'Buy' rating and a specific target of £6.75 by Numis. Conversely, Goldman Sachs took a bearish turn on Entain PLC, slashing its price target from £14.50 to £8.20 and downgrading the stock from 'Buy' to 'Sell'.

In the energy sector, RBC Capital Markets has raised its sights on BP (NYSE: BP ) PLC, setting an elevated target of £6.25 (GBP1 = USD1.2619) due to anticipated outperformance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100